CDK5 and drug-induced dyskinesia: In contexts where high BK current densities in striatal cholinergic neurons are associated with hyperexcitability of cholinergic neurons, the novel CDK5 activator may provide an intervention target to suppress dyskinesia-like behaviors in neurological disorders.